Logo image of RCFA

PERCEPTION CAPITAL CORP IV (RCFA) Stock Fundamental Analysis

NYSE:RCFA - New York Stock Exchange, Inc. - KYG7330C1024 - Common Stock - Currency: USD

11.45  -0.05 (-0.43%)

Fundamental Rating

1

Overall RCFA gets a fundamental rating of 1 out of 10. We evaluated RCFA against 0 industry peers in the Unkown industry. RCFA has a bad profitability rating. Also its financial health evaluation is rather negative. RCFA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year RCFA was profitable.
RCFA had a negative operating cash flow in the past year.
RCFA Yearly Net Income VS EBIT VS OCF VS FCFRCFA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 5M 10M

1.2 Ratios

Industry RankSector Rank
ROA 4.48%
ROE 4.79%
ROIC N/A
ROA(3y)6.11%
ROA(5y)N/A
ROE(3y)7.03%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RCFA Yearly ROA, ROE, ROICRCFA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 5 -5 10

1.3 Margins

RCFA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RCFA Yearly Profit, Operating, Gross MarginsRCFA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for RCFA has been reduced compared to 1 year ago.
The debt/assets ratio for RCFA is higher compared to a year ago.
RCFA Yearly Shares OutstandingRCFA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
RCFA Yearly Total Debt VS Total AssetsRCFA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

RCFA has an Altman-Z score of 20.72. This indicates that RCFA is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.02 indicates that RCFA is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 20.72
ROIC/WACCN/A
WACCN/A
RCFA Yearly LT Debt VS Equity VS FCFRCFA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

RCFA has a Current Ratio of 0.13. This is a bad value and indicates that RCFA is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.13 indicates that RCFA may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.13
RCFA Yearly Current Assets VS Current LiabilitesRCFA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for RCFA have decreased strongly by -63.56% in the last year.
EPS 1Y (TTM)-63.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-149.5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RCFA Yearly Revenue VS EstimatesRCFA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023
RCFA Yearly EPS VS EstimatesRCFA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 95.42, the valuation of RCFA can be described as expensive.
Compared to an average S&P500 Price/Earnings ratio of 29.63, RCFA is valued quite expensively.
Industry RankSector Rank
PE 95.42
Fwd PE N/A
RCFA Price Earnings VS Forward Price EarningsRCFA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RCFA Per share dataRCFA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RCFA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PERCEPTION CAPITAL CORP IV

NYSE:RCFA (11/15/2024, 8:04:01 PM)

11.45

-0.05 (-0.43%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-22 2024-11-22
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners35.99%
Ins Owner Change0%
Market Cap121.03M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 95.42
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.37
P/tB 2.37
EV/EBITDA N/A
EPS(TTM)0.12
EY1.05%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS0
BVpS4.84
TBVpS4.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.48%
ROE 4.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)6.11%
ROA(5y)N/A
ROE(3y)7.03%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.13
Quick Ratio 0.13
Altman-Z 20.72
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-63.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-149.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y64.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-73.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-73.5%
OCF growth 3YN/A
OCF growth 5YN/A